A meta-analysis of prior corticosteroid use and fracture risk

Journal of Bone and Mineral Research

Volumn 19, Issue 6, 2004, Pages 893-899

  Kanis, John A ^a   Johansson, Helena ^b   Oden, Anders ^b   Johnell, Olof ^c   De Laet, Chris ^d   Joseph Melton III, L ^e   Tenenhouse, Alan ^f   Reeve, Jonathan ^g   Silman, Alan J ^h   Pols, Huibert A P ⁱ   Eisman, John A ^j   McCloskey, Eugene V ^a   Mellstrom, Dan ^k  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Malmo General Hospital ^*

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MAYO CLINIC   (United States)

^f MONTREAL GENERAL HOSPITAL   (Canada)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^j GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^k UNIVERSITY OF GOTHENBURG   (Sweden)

more..

Author keywords

Corticosteroids; Fracture risk; Fracture threshold; Meta analysis

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; FEMUR FRACTURE; FEMUR NECK; FOLLOW UP; FRACTURE; HUMAN; META ANALYSIS; OSTEOPOROSIS; RISK FACTOR; SEX RATIO; VALIDATION PROCESS; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MIDDLE AGED; PROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; AGED; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 4143136738     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.040134     Document Type: Article

References (28)

1. Hooyman JR, Melton LJ, Melson AM, O'Fallon WM, Riggs BL 1984 Fractures after rheumatoid arthritis - a population based study. Arthritis Rheum 27:1353-1361.
2. Cooper C, Coupland C, Mitchell M 1995 Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Ann Rheum Dis 54:49-52.
3. Van Staa TP, Leufkens HGM, Cooper C 2002 The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporos Int 13:777-787.
4. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C 2000 Fracture and oral corticosteroids: Relationship to daily and cumulative dose. Rheumatology (Oxford) 39:1383-1389.
5. American College of Rheumatology, Ad Hoc Committee on glucocorticosteroid-induced osteoporosis 2001 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496-1503.
6. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM 1998 A UK consensus group on management of glucocorticoid induced osteoporosis: An update. J Intern Med 244:271-292.
7. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D on behalf of the European Foundation for Osteoporosis (EFFO) 1997 Guidelines for the diagnosis and management of osteoporosis. Osteoporos Int 7:390-406.
8. Bone and Tooth Society of Great Britain, National Osteoporosis Society, and Royal College of Physicians 2002 Guidelines on the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Royal College of Physicians, London, UK.
9. Royal College of Physicians 1999 Osteoporosis: Clinical Guidelines for Prevention and Treatment. Royal College of Physicians, London, UK.
10. Royal College of Physicians 2000 Osteoporosis: Clinical Guidelines for Prevention and Treatment. Update on Pharmacological Interventions and an Algorithm for Management. Royal College of Physicians, London, UK.
11. Johansson H, Oden A, Johnell O, Jonsson B, De Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA 2004 Optimization of BMD measurements to identify high risk groups for treatment - a test analysis. J Bone Miner Res 19:906-913.
12. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA 1991 Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7:403-422.
13. De Laet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP 1998 Hip fracture prediction in elderly men and women: Validation of the Rotterdam Study. J Bone Miner Res 13:1587-1593.
14. Johansson C, Black D, Johnell O, Oden A, Mellstrom D 1998 Bone mineral density is a predictor of survival. Calcif Tissue Int 63:190-196.
15. Jones G, Nguyen TV, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA 1994 Symptomatic fracture incidence in elderly men and women. The Dubbo osteoporosis Epidemiology Study DOES. Osteoporos Int 4:277-282.
16. Kreiger N, Tenenhouse A, Joseph L, MacKenzie T, Poliquin S, Brown JP, Prior JE, Rittmaster RS 1999 The Canadian Multicentre Osteoporosis Study CaMos: Background, rationale, methods. Can J Ageing 18:376-387.
17. Melton LJ III, Crowson CS, O'Fallon WM, Wahner HW, Riggs BL 2003 Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 18:312-318.
18. Melton LJ III, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL 1998 Bone density and fracture risk in men. J Bone Miner Res 13:1915-1923.
19. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ 1996 The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010-1017.
20. Felsenberg D, Silman AJ, Lunt M, Ambrecht G, Ismail AA, Finn JD, Cockerill WC, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Dequeker J, Eastell R, Ershova O, Felsch B, Gowin W, Havelka S, Hoszowski K, Jajic I, Janot J, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Masaryk P, Matthis C, Miazgowski T, Parisi G, Pols HAP, Poor G, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, Reeve J, O'Neill TW 2002 Incidence of vertebral fracture in Europe: Results from the European Prospective Osteoporosis Study EPOS. J Bone Miner Res 17:716-724.
21. Ismail AA, Pye SR, Cockerill WC, Lunt M, Silman AJ, Reeve J, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Delmas PD, Dequeker J, Dilsen G, Falch JA, Felsch B, Felsenberg D, Finn JD, Gennari C, Hoszowski K, Jajic I, Janott J, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Marchand F, Masaryk P, Matthis C, Miazgowski T, Naves-Diaz M, Pols HAP, Poor G, Rapado A, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, O'Neill TW 2002 Incidence of limb fracture across Europe: Results from the European prospective osteoporosis study EPOS. Osteoporos Int 13:565-571.
22. Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A 2002 The burden of osteoporotic fractures: A method for setting intervention thresholds. Osteoporos Int 12:417-424.
23. Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas P, Ribot C, Sebert JL, Breart G, Meunier PJ 1998 How hip and whole-body bone mineral density predict hi fracture in elderly women: The EPIDOS Prospective Study. Osteoporos Int 8:247-254.
24. Aaron JE, Francis RM, Peacock M, Makins NB 1989 Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop 243:294-305.
25. Chappard D, Legrand E, Basle MF, Fromont P, Racineux JL, Rebie A, Audran M 1996 Altered trabecular architecture induced by corticosteroids: A bone histomorphometric study. J Bone Miner Res 11:676-685.
26. Manolagas SC 2000 Corticosteroids and fracture: A close encounter of the third kind. J Bone Miner Res 15:1001-1005.
27. Kanis JA 2002 Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936.
28. Anonymous 2002 Osteoporose Tweede Herziene Richtlijn. CBO Utrecht.